Sanofi : Sanofi Offers to Acquire Medivation for $52.50 Per Share in Cash
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil hovers near $100 on rising Middle East tensions
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Medivation (MDVN) Expected to Reject Sanofi (SNY) Bid; Sanofi May Abandon Effort - Source
April 28, 2016 12:31 PM EDTMedivation (Nasdaq: MDVN) is expected to reject Sanofi's (NYSE: SNY) $52.50 per share proposal to takeover the company, according to a source familiar with the situation.
Morgan Stanley is also expected to advise Sanofi (NYSE: SNY) to abandon the takeover effort.
Shares of Medivation are up over 8.5 percent.
... MoreSanofi Has Room for Higher Medivation (MDVN) Bid, Credit Suisse Says; Deal Could Be 7% Accretive in 2020 at $80
April 28, 2016 10:33 AM EDTCredit Suisse analyst Kennen MacKay weighs in on Medivation (NASDAQ: MDVN) after Sanofi launched a $52.50/share hostile bid.
The firm's recent takeover analysis suggested MDVN could be worth $55/share to Sanofi and beleives their conservative estimates indicate Sanofi has more... More
Medivation (MDVN) Affirms Receipt of $52.50/Share Takeover Offer from Sanofi (SNY); Will Review
April 28, 2016 9:13 AM EDTMedivation, Inc. (NASDAQ: MDVN) confirmed that it has received an unsolicited, non-binding proposal from Sanofi to acquire all outstanding shares of Medivation common stock for $52.50 in cash.
On April 15, 2016, Medivation's Board of Directors received a private letter from Sanofi making an indicative,... More
